Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-88,151
Closed -$2.47M 5164
2016
Q4
$2.47M Sell
88,151
-5,786
-6% -$162K ﹤0.01% 1148
2016
Q3
$2.58M Sell
93,937
-36,692
-28% -$1.01M ﹤0.01% 1110
2016
Q2
$2.85M Buy
130,629
+105,393
+418% +$2.3M ﹤0.01% 1022
2016
Q1
$564K Buy
25,236
+19,196
+318% +$429K ﹤0.01% 1529
2015
Q4
$167K Buy
6,040
+1,821
+43% +$50.3K ﹤0.01% 1687
2015
Q3
$109K Sell
4,219
-946
-18% -$24.4K ﹤0.01% 1710
2015
Q2
$128K Sell
5,165
-50
-1% -$1.24K ﹤0.01% 1755
2015
Q1
$131K Hold
5,215
﹤0.01% 1736
2014
Q4
$122K Hold
5,215
﹤0.01% 1664
2014
Q3
$119K Hold
5,215
﹤0.01% 1669
2014
Q2
$128K Sell
5,215
-6,200
-54% -$152K ﹤0.01% 1651
2014
Q1
$241K Sell
11,415
-1,438
-11% -$30.4K ﹤0.01% 1495
2013
Q4
$306K Sell
12,853
-65
-0.5% -$1.55K ﹤0.01% 1495
2013
Q3
$276K Hold
12,918
﹤0.01% 1419
2013
Q2
$257K Buy
+12,918
New +$257K ﹤0.01% 1426

Other funds holding QGENF

BlackRock's QGENF Position: Q1 2017 in Review

BlackRock sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 88,151 shares — an estimated $2.47M sold.

BlackRock first reported a position in QGENF in Q2 2013 and held it in 15 quarters. The position peaked at $2.85M in Q2 2016. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • BlackRock reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • BlackRock sold 88,151 QIAGEN NV shares in Q1 2017, an estimated $2.47M.
  • BlackRock first reported a position in QIAGEN NV in Q2 2013 and held it in 15 quarters.
  • BlackRock's QIAGEN NV position peaked at $2.85M in Q2 2016.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on BlackRock's 13F filing for Q1 2017, filed 12 May 2017.